MGX
Metagenomi Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.81
+3.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.27x
- Price / sales
- 2.26x
- Price / cash flow
- -0.36x
Enterprise value
- Enterprise value
- -$52.3M
- EV / sales
- -3.85x
- EV / EBITDA
- 0.59x
- EV / EBIT
- 0.52x
- Market cap
- $30.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026